Highlights from our recent research

A review of 2025 and an outlook for 2026 and beyond, covering transactions in North America, Europe, Asia, Latin America, and Africa.

We outline considerations on evaluating medication suitability for manufacturers looking to expand their presence in the direct-to-patient market.

The toll of 2025’s extreme weather events across Europe—and steps insurers can take now to reduce the financial risks posed by climate change.